Aurora Cannabis, Hexo, And Valens Among Canadian Cannabis Stocks Expected To Thrive As The Industry Rebounds

In the last two years, the cannabis industry has faced a myriad of challenges but the COVID-19 pandemic has brought new realities for Canadian cannabis stocks. Cannabis stocks experienced a surge in demand for pot during the COVID-19 lockdown leading to several operators reporting exceptional results in the recent quarter.

Aurora Cannabis among thriving Canadian cannabis stocks

One of the companies that reported exceptional results recently is Aurora Cannabis (NYSE:ACB). The company is better positioned to continue thriving following a series of measures to conserve cash because of growing cash concerns. The trigger for Aurora Cannabis was its value brand shift to Daily Special at the beginning of Q1 2020.

The company’s recreational cannabis sales grew by CA$8 million sequentially to CA$42 million. Aurora shifted its focus to value brands hence the exceptional results. In February the company changed its focus from the most international location to a focus on domestic, US, and Germany markets.

Hexo instituting cash saving measures

Hexo Corp (NYSE:HEXO) is another Canadian player that is trying to get its act together and it instituted a series of measures to conserve cash. Last year the company’s top Gatineau facility was on track and the company boosted its production through the acquisition of Newstrike Brands.

However, cash problems have forced the company to close and sell its Niagara facility that it acquired through the Newstrike deal. The cannabis operator has also laid-off most of its staff as well as idled most of its cultivation area at the Gatineau facility.

Valens Groworks stock up 27% in 2020

Valens Groworks Corp (TSE:VLNS) has also performed exceptionally with its stock jumping 27% since the beginning of the year. The company is positioning itself as a marijuana manufacturing company instead of an extractor through the transformation of its business models with a focus on the domestic Canadian market. In its recent quarter, Valens reported revenues of $31 million and for fiscal 2020 the company expects to generate revenue of around $138 million.

This article by Money News National is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Money News National has no position in the stocks mentioned. Thank you for reading.


This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.


Please enter your comment!
Please enter your name here